examin
efficaci
combin
subunit
antigenbas
oral
vaccin
prevent
porcin
epidem
diarrhea
viru
pedv
first
gener
solubl
recombin
partial
spike
protein
pedv
e
coli
evalu
util
subunit
vaccineload
hydroxypropyl
methylcellulos
phthalat
microspher
hpmcp
ranklsecret
l
lacti
llrankl
candid
oral
vaccin
pregnant
sow
pregnant
sow
vaccin
twice
week
interv
dose
week
farrow
titer
virusspecif
iga
antibodi
colostrum
neutral
antibodi
serum
sow
vaccin
hpmcp
plu
rankl
increas
significantli
week
postfirst
vaccin
furthermor
surviv
rate
newborn
suckl
piglet
deliv
sow
vaccin
hpmcp
plu
rankl
similar
piglet
deliv
sow
vaccin
commerci
kill
porcin
epidem
diarrhea
viru
ped
vaccin
south
korean
govern
promot
ped
vaccin
program
livekilledkil
increas
titer
iga
igg
antibodi
pregnant
sow
prevent
pedv
oral
vaccin
strategi
describ
herein
base
safe
effici
recombin
subunit
antigen
altern
ped
vaccin
strategi
could
replac
tradit
strategi
reli
attenu
live
oral
vaccin
artifici
infect
virul
pedv
porcin
epidem
diarrhea
ped
highli
infecti
contagi
enter
diseas
swine
song
park
diseas
character
sever
diarrhea
vomit
dehydr
death
mortal
rate
among
suckl
piglet
lee
porcin
epidem
diarrhea
viru
pedv
caus
agent
ped
rna
viru
belong
alpha
genu
coronaviru
famili
wang
et
al
spike
protein
primari
target
develop
subunit
vaccin
pedv
protein
pedv
compris
two
domain
amino
acid
aa
aa
transmembran
glycoprotein
local
virion
surfac
sun
et
al
protein
play
pivot
role
bind
cellular
receptor
fusion
target
cell
membran
importantli
induct
neutral
antibodi
song
park
subsequ
novel
neutral
epitop
aa
identifi
domain
epitop
respons
induct
neutral
antibodi
pedv
sun
et
al
date
number
express
system
use
gener
protein
pedv
includ
mammalian
cell
transgen
plant
yeast
e
coli
sun
et
al
kang
et
al
oh
et
al
park
et
al
despit
absenc
posttransl
modif
ie
phosphoryl
acetyl
glycosyl
express
recombin
protein
e
coli
mark
advantag
express
system
term
cost
easeofus
scale
howev
express
recombin
protein
e
coli
often
lead
misfold
protein
interest
biolog
inact
aggreg
known
inclus
bodi
ib
yamaguchi
miyazaki
iga
titer
colostrum
milk
correl
pedv
neutral
antibodi
titer
provid
protect
immun
pedv
optim
vaccin
regimen
induc
high
level
type
antibodi
lactogen
secret
vaccin
sow
lee
langel
et
al
song
et
al
synthet
natur
polym
includ
enter
coat
polym
evalu
vehicl
deliv
protein
gastrointestin
gi
tract
hydroxypropyl
methylcellulos
phthalat
hpmcp
exampl
enter
coat
excipi
use
wide
pharmaceut
industri
singh
et
al
ranklrank
system
play
import
role
develop
regul
immun
system
exampl
involv
lymphnod
organogenesi
lymphocyt
differenti
dendrit
cell
surviv
tcell
activ
promot
function
antigenpres
cell
maharjan
et
al
therefor
increas
number
microfold
cell
cell
deliv
rankl
may
promis
biomimet
strategi
increas
efficaci
oral
vaccin
kim
et
al
oral
vaccin
pregnant
sow
induc
lactogen
immun
fundament
strategi
use
protect
suckl
pig
infect
pedv
langel
et
al
extent
protect
depend
presenc
virusspecif
iga
antibodi
milk
immun
sow
use
ecoli
express
system
gener
solubl
protein
express
neutral
epitop
pedv
domain
protein
express
epitop
aa
elicit
format
neutral
antibodi
pedv
strain
domain
sun
et
al
next
develop
hpmcp
microspher
test
efficaci
oral
vaccin
candid
prevent
ped
moreov
use
rankl
ligandsecret
l
lacti
oral
adjuv
combin
oral
vaccin
strategi
evalu
pregnant
sow
addit
protect
efficaci
vaccin
evalu
challeng
newborn
suckl
piglet
korean
virul
field
pedv
strain
recombin
e
coli
strain
harbor
express
vector
piao
et
al
use
gener
solubl
antigen
antigen
compris
epitop
aa
domain
protein
pedv
strain
genbank
access
antigen
synthes
codonoptim
use
genscript
piscataway
nj
usa
seed
cultur
prepar
inocul
singl
coloni
recombin
e
coli
strain
ml
steril
plastic
tube
contain
ml
lb
broth
supplement
ampicillin
cultur
grown
overnight
express
recombin
protein
seed
cultur
routin
inocul
ml
lb
broth
contain
ampicillin
cell
cultur
shake
rpm
od
cultur
reach
recombin
protein
induc
addit
mm
iptg
cultur
h
induct
cell
harvest
centrifug
store
requir
purifi
ib
cell
l
cultur
recombin
strain
harvest
centrifug
min
g
wash
twice
distil
water
lyse
lysi
buffer
mm
trishcl
ph
contain
mgml
lysozym
mgml
dnase
h
cell
disrupt
sonic
min
use
son
soff
cycl
amplitud
result
suspens
centrifug
min
g
next
pellet
wash
three
time
lysi
buffer
ii
lysi
buffer
contain
triton
purifi
ib
collect
centrifug
min
g
concentr
purifi
ib
determin
sdspage
densitometri
use
bsa
standard
solubl
recov
ib
use
alkalin
ph
solubil
method
describ
previous
piao
et
al
briefli
ib
obtain
l
cell
cultur
solubil
ml
alkalin
ph
buffer
mm
trishcl
ph
supernat
collect
centrifug
min
g
solubil
protein
precipit
ad
four
volum
icecold
aceton
follow
centrifug
min
g
remov
supernat
pellet
wash
ml
icecold
aceton
follow
contrifug
min
g
aceton
evapor
airdri
min
room
temperatur
pellet
dissolv
immedi
distil
water
hpmcp
obtain
shinetsu
chemic
co
ltd
tokyo
japan
solubl
mg
dissolv
ml
distil
water
stabil
pluron
solut
wt
form
intern
aqueou
phase
next
ml
mg
emulsifi
min
organ
phase
compris
mg
hpmcp
dissolv
ml
dichloromethan
dcm
use
ultrason
processor
vibra
cell
usa
output
w
form
primari
emuls
prepar
primari
emuls
ad
drop
wise
ml
wt
pva
solut
creat
extern
aqueou
phase
homogen
homogen
ika
min
g
form
emuls
stir
magnet
stirrer
h
room
temperatur
allow
solvent
evapor
synthes
microparticl
collect
centrifug
g
min
wash
three
time
distil
water
microspher
lyophil
store
prior
character
surfac
topographi
averag
size
microparticl
analyz
fieldemiss
scan
electron
microscopi
fesem
use
supra
v
p
scan
electron
microscop
carl
zeiss
oberkochen
germani
prior
examin
microparticl
mount
metal
stub
use
thin
adhes
tape
coat
gold
coat
chamber
ct
h
f
oxford
instrument
oxfordshir
uk
vacuum
amount
antigen
encapsul
per
unit
weight
microparticl
determin
follow
mg
dri
microparticl
dissolv
naoh
solut
ph
contain
sd
themixtur
vortex
vigor
incub
room
temperatur
h
centrifug
g
min
aqueou
solut
withdrawn
content
calcul
bca
protein
assay
sdspage
densitometri
use
bsa
standard
encapsul
effici
express
ratio
actual
amount
load
antigen
total
amount
antigen
use
prepar
microparticl
encapsul
effici
antigen
load
calcul
use
follow
equat
load
effici
amount
protein
microspher
amount
protein
initi
use
load
content
amount
protein
microspher
amount
microspher
hpmcp
microspher
mg
suspend
ml
small
intestin
fluid
ph
ml
gastrointestin
fluid
ph
pig
agit
h
shake
rpm
next
aliquot
withdrawn
releas
medium
time
point
replac
equal
volum
fluid
amount
releas
protein
determin
cumul
releas
wt
incub
time
use
micro
protein
assay
kit
thermofish
scientif
com
cat
week
parturit
ten
pregnant
sow
serolog
neg
pedv
neutral
antibodi
vaccin
twice
week
interv
dose
hpmcp
microspher
contain
mg
via
oral
group
intramuscular
im
group
rout
anoth
group
pig
receiv
oral
vaccin
cfu
ranklsecret
l
lacti
group
control
group
group
receiv
im
vaccin
commerci
ped
vaccin
commerci
kill
vaccin
strain
use
regimen
final
anoth
control
group
group
mockvaccin
tabl
serum
sampl
collect
pregnant
sow
week
postvaccin
time
farrow
colostrum
sampl
collect
lactat
sow
time
deliveri
whey
separ
colostrum
test
viru
neutral
assay
offspr
suckl
piglet
hous
sow
receiv
artifici
colostrum
milk
threedayold
piglet
select
random
farrow
sow
vaccin
control
group
challeng
virul
pedv
briefli
suck
piglet
transport
farm
environment
control
facil
anim
plant
quarantin
agenc
apqa
receiv
artifici
milk
four
time
daili
suckl
piglet
age
day
challeng
oral
mldose
tcid
ml
wildtyp
virul
pedv
strain
genbank
access
clinic
sign
diarrhea
morbid
mortal
monitor
three
time
daili
day
post
challeng
dpc
rectal
swab
collect
bodi
weight
check
everi
day
day
prechalleng
dpc
diarrhea
score
daili
first
dpc
everi
day
thereaft
fecal
consist
score
follow
solid
pasti
semiliquid
liquid
qrtpcr
perform
detect
ped
antigen
copi
number
fecal
swab
sampl
assess
pedv
shed
challeng
anyq
pedv
qrtpcr
mediandiagnost
co
cat
korea
use
taqman
probe
detect
pedv
spike
region
use
accord
manufactur
instruct
rtpcr
program
compris
follow
step
cdna
synthesi
min
initi
inactiv
min
follow
twostep
pcr
compris
cycl
denatur
annealingextens
iga
level
colostrum
test
use
ped
iga
elsia
kit
bionot
co
cat
south
korea
mean
od
standard
neg
ncx
standard
posit
pcx
control
respect
interpret
result
base
cutoff
valu
calcul
follow
cutoff
valu
vhcd
ratio
jejunum
ileum
measur
six
villi
per
intestin
section
moribund
piglet
show
sign
anorexia
dehydr
period
h
euthan
instruct
institut
veterinarian
studi
approv
anim
care
use
committe
apqa
anim
experi
perform
accord
guidelin
apqa
anim
care
use
committe
statist
analys
perform
use
graphpad
prism
softwar
version
window
data
analyz
use
oneway
analysi
varianc
follow
tukey
multiplecomparison
test
tabl
group
show
signific
differ
p
time
point
indic
differ
letter
scan
electron
microscopi
sem
imag
hpmcp
microspher
reveal
microspher
diamet
size
sphere
fig
hpmcp
microspher
mg
dissolv
naoh
ph
buffer
contain
sd
amount
releas
protein
determin
bca
assay
optim
load
content
effici
respect
band
intens
protein
similar
bsa
standard
fig
vitro
timedepend
releas
hpmcp
microspher
assess
small
intestin
fluid
ph
gastrointestin
fluid
ph
pig
design
environ
gi
pig
suspend
mg
hpmcp
microspher
ml
small
intestin
fluid
ph
gastrointestin
fluid
ph
agit
rpm
h
almost
wt
releas
microspher
within
h
ph
contrast
less
wt
releas
within
h
ph
fig
titer
serum
neutral
antibodi
vaccin
sow
increas
log
log
week
first
vaccin
fig
neutral
antibodi
titer
colostrum
whey
sampl
vaccin
sow
higher
log
sow
control
group
log
fig
mean
gestat
period
day
averag
number
piglet
tabl
birth
number
surviv
piglet
rang
averag
averag
number
stillborn
piglet
bodi
weight
live
piglet
sow
vari
tabl
none
pregnant
sow
show
clinic
sign
side
effect
vaccin
cutoff
valu
ped
iga
elisa
od
od
valu
colostrum
sow
group
neg
sow
group
inocul
kill
ped
posit
fig
iga
level
colostrum
whey
sampl
sow
inocul
oral
hpmcp
plu
rankl
vaccin
group
significantli
higher
respect
sampl
mockvaccin
sow
p
fig
challeng
pedv
piglet
group
mock
control
die
dpc
piglet
group
inocul
im
hpmcp
vaccin
alon
die
dpc
fig
one
fourteen
piglet
group
inocul
oral
hpmcp
vaccin
alon
surviv
wherea
remaind
die
dpc
fig
half
piglet
born
sow
group
inocul
commerci
kill
ped
vaccin
surviv
fig
half
piglet
born
sow
inocul
hpmcp
plu
rankl
vaccin
group
fig
sever
villou
atrophi
infect
pig
quantifi
measur
ratio
villu
height
crypt
depth
vh
cd
ratio
villou
atrophi
ileum
piglet
born
sow
vaccin
hpmcp
plu
rankl
vaccin
significantli
milder
mock
group
piglet
p
fig
villou
atrophi
jejunum
piglet
born
sow
vaccin
commerci
kill
vaccin
strain
oral
hpmcp
plu
rankl
significantli
milder
mock
group
piglet
p
fig
sixteen
piglet
born
sow
group
experienc
diarrhea
dpc
averag
diarrhea
score
ad
dpc
dpc
dpc
dpc
dpc
dpc
dpc
p
fig
piglet
group
commerci
kill
ped
vaccin
began
diarrhea
dpc
ad
lower
group
dpc
dpc
dpc
dpc
dpc
dpc
dpc
dpc
dpc
fig
piglet
group
sow
inocul
oral
hpmcp
plu
rankl
vaccin
also
show
low
longlast
ad
dpc
dpc
dpc
dpc
dpc
dpc
dpc
dpc
dpc
fig
piglet
group
show
signific
bodi
weight
loss
suckl
piglet
born
mock
sow
lost
mean
bodi
weight
dpc
wherea
piglet
born
sow
inocul
oral
hpmcp
lost
mean
bodi
weight
dpc
p
fig
contrast
piglet
born
sow
inocul
commerci
kill
vaccin
lost
bodi
weight
dpc
howev
dpc
bodi
weight
recov
prior
pedv
challeng
fig
piglet
born
sow
inocul
oral
hpmcp
plu
rankl
vaccin
group
also
lost
bodi
weight
dpc
howev
surviv
piglet
regain
lost
weight
dpc
fig
imag
hpmcp
microspher
microspher
size
spheric
sdspage
analysi
releas
hpmcp
microparticl
b
total
lane
lane
releas
load
intens
protein
band
compar
bsa
standard
lane
viral
rna
copi
number
fece
piglet
group
log
g
dpc
log
dpc
copi
number
peak
log
dpc
fig
copi
number
piglet
vaccin
commerci
kill
vaccin
log
dpc
log
dpc
peak
log
dpc
fig
piglet
vaccin
oral
hpmcp
plu
rankl
vaccin
show
lower
copi
number
group
copi
number
piglet
group
follow
dpc
log
dpc
dpc
dpc
dpc
dpc
dpc
dpc
dpc
fig
newborn
piglet
reli
matern
lactogen
immun
suppli
via
colostrum
milk
saif
jackwood
natur
infect
oral
immun
live
viru
gener
suffici
mucos
lactogen
immun
wherea
intramuscular
administr
induc
system
immun
respons
provid
littl
lactogen
immun
song
et
al
chattha
et
al
gener
subunit
oral
vaccin
show
poor
immunogen
although
toxin
adjuv
cholera
toxin
e
coli
heatlabil
toxin
act
mucos
vaccin
adjuv
obviou
safeti
concern
prevent
use
clinic
set
kim
et
al
notabl
recent
studi
demonstr
import
receptor
activ
nfkb
ligand
rankl
control
cell
differenti
peyer
patch
knoop
et
al
gener
solubl
protein
contain
pedv
load
phsensit
hpmcp
microspher
sem
imag
reveal
microspher
rang
size
spheric
size
microspher
affect
uptak
apc
cell
particl
smaller
may
transfer
drain
lymph
node
spleen
stimul
mucos
system
immun
respons
particl
size
measur
retain
peyer
patch
stimul
mainli
mucos
immun
respons
particl
measur
larg
taken
immun
cell
cell
load
content
effici
hpmcp
microspher
respect
moreov
vitro
releas
test
reveal
releas
microspher
within
h
ph
releas
ph
suggest
hpmcp
suitabl
oral
vaccin
phsensit
polym
dissolv
ph
observ
rapid
dissolut
hpmcp
microspher
may
due
ph
pb
far
higher
gi
ph
gradient
stomach
ileum
therefor
assum
choe
et
al
veterinari
microbiolog
releas
slowli
hpmcp
microspher
pass
stomach
rapidli
approach
ileum
colostrum
neutral
antibodi
titer
sow
vaccin
intramuscularli
hpmcp
microspher
log
suggest
humor
immun
respons
induc
deffici
inject
hpmcp
microspher
virusneutr
igg
antibodi
transfer
colostrum
farrow
sow
vaccin
oral
hpmcp
microspher
alon
microspher
plu
rankl
adjuv
show
higher
serum
colostrum
neutral
antibodi
titer
mockvaccin
sow
suggest
humor
mucos
immun
respons
induc
effici
matern
lkk
attenu
live
vaccinekil
vaccinekil
vaccin
vaccin
efficaci
kk
vaccin
term
absolut
improv
surviv
rate
signific
mitig
diarrhea
well
quantiti
durat
viral
shed
stool
jang
et
al
oral
vaccin
sow
hpmcp
plu
rankl
induc
high
neutral
antibodi
titer
serum
colostrum
whey
induc
iga
antibodi
colostrum
whey
mortal
rate
piglet
deliv
sow
vaccin
hpmcp
plu
rankl
piglet
deliv
sow
vaccin
commerci
kill
ped
vaccin
therefor
current
oral
vaccin
strategi
base
recombin
subunit
antigen
conjunct
hpmcp
carrier
rankl
adjuv
could
novel
altern
vaccin
strategi
prevent
ped
lactogen
immun
describ
continu
suppli
passiv
acquir
immunoglobulin
igg
igm
siga
ingest
colostrum
milk
klobasa
butler
depend
traffick
pathogenspecif
iga
plasmablast
mammari
gland
mg
accumul
secretori
iga
siga
antibodi
milk
defin
gutmgsiga
axi
bohl
saif
bohl
et
al
fink
matern
vaccin
increas
amount
protect
antibodi
induc
via
gutmgsiga
axi
passiv
transfer
milk
strategi
use
protect
suckl
piglet
pedv
immedi
birth
langel
et
al
chattha
et
al
increas
rate
protect
associ
high
titer
iga
antibodi
colostrum
milk
expect
suckl
piglet
challeng
experi
perform
piglet
cohabit
vaccin
sow
ie
piglet
receiv
pedsigacontain
milk
surviv
rate
challeng
virul
viru
would
higher
milk
sow
vaccin
hpmcp
microspher
plu
rankl
contain
siga
specif
pedv
continu
milk
intak
would
increas
immun
pedv
demonstr
enter
viral
infect
stimul
intestin
mucosa
therebi
influenc
lactogen
immun
via
gutmgsiga
axi
langel
et
al
chattha
et
al
mani
swine
research
south
korea
promot
ped
vaccin
program
livekilledkil
increas
iga
igg
antibodi
product
pregnant
sow
ensur
effect
prevent
pedv
korea
lkk
vaccin
program
involv
continu
inocul
pregnanc
rais
iga
igg
antibodi
titer
pregnant
sow
colostrum
fed
piglet
lkk
vaccin
program
involv
vaccin
pregnant
sow
three
time
first
vaccin
live
attenu
ped
vaccin
week
deliveri
follow
two
vaccin
kill
vaccin
week
week
deliveri
optim
time
day
gestat
middl
period
pregnanc
oral
vaccin
increas
matern
immun
lactogen
immun
least
week
previou
studi
examin
surviv
piglet
born
sow
infect
pedv
earli
middl
termin
stage
pregnanc
langel
et
al
piglet
born
sow
infect
midgest
surviv
compar
earli
gestat
group
late
gestat
group
langel
et
al
thu
matern
immun
lactogen
immun
strongest
sow
expos
pedv
midgest
period
addit
diarrhea
score
viru
shed
neonat
suckl
piglet
pedv
challeng
low
langel
et
al
therefor
propos
immun
hpmcp
microspher
plu
rankl
like
effect
midpregn
period
conclus
iga
titer
matern
colostrum
sow
vaccin
hpmcp
microspher
plu
rankl
play
import
role
prevent
virul
pedv
suckl
piglet
surviv
rate
piglet
deliv
group
sow
piglet
born
sow
vaccin
commerci
ped
kill
vaccin
exist
lkk
vaccin
program
effici
howev
live
attenu
strain
potenti
pathogen
revers
virul
pedv
use
artifici
infect
may
propag
continu
outdoor
pig
farm
expect
novel
vaccin
describ
herein
address
issu
anim
experi
approv
anim
plant
quarantin
agenc
ministri
agricultur
food
rural
affair
author
declar
compet
interest
